The Prevention of Vertical Transmission of HBV
A special issue of Tropical Medicine and Infectious Disease (ISSN 2414-6366). This special issue belongs to the section "Infectious Diseases".
Deadline for manuscript submissions: closed (28 August 2023) | Viewed by 2810
Special Issue Editors
Interests: prevention and control of hepatitis B; addressing vaccine hesitancy.
Interests: viral hepatitis; viral hepatitis elimination; eliminating mother-to-child transmission; hepatitis B vaccination
Special Issue Information
Dear Colleagues,
The World Health Organization (WHO) Global Health Sector Strategy on Viral Hepatitis 2016–2021, aimed to eliminate viral hepatitis as a major public health threat by 2030. The strategy called on all WHO-member countries to invest in five interventions, one of which was aimed at preventing mother-to-child transmission of hepatitis B virus (HBV). This intervention included providing universal hepatitis B vaccination (Hep B) to newborns within 24 hours of birth, together with routine antenatal screening and antiviral treatment of HBV-positive pregnant women. With only 38% of newborns globally in 2015 having received a timely HepB birth dose, the WHO set ambitious 2020 and 2030 coverage targets of 50% and 90%, respectively. However, the 2020 target was not met, and in 2021 only 42% of newborns globally had received a timely Hep B birth dose. Nevertheless, in 2022, the WHO added another ambitious coverage target of 70% to be reached by 2025, and retained the 2030 target of 90% coverage. By focusing on the prevention of vertical transmission of HBV in this Special Issue, we aim to support the WHO in reaching these ambitious targets to eliminate hepatitis B by 2030. We encourage authors to submit reviews, meta-analyses, and original research, providing much-needed evidence for Ministries of Health to justify the introduction of (a) universal Hep B vaccination within 24 hours of birth, and (b) routine antenatal screening and antiviral treatment of HBV-positive pregnant women.
Prof. Dr. Rosemary Joyce Burnett
Prof. Dr. Mark Wayne Sonderup
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prevalence of vertical transmission of HBV
- cost-effectiveness of interventions preventing vertical transmission of HBV
- hep B birth-dose coverage
- antenatal HBV screening coverage
- prevalence of HBV mono-infection in pregnant women
- prevalence of HIV/HBV co-infection in pregnant women
- treatment of HBV mono-infection in pregnant women
- treatment of HIV/HBV co-infection in pregnant women
- progress towards eliminating hepatitis B
